Jane Street
AVXL icon

Jane Street’s Anavex Life Sciences AVXL Stock Holding History

Jane Street’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-66,500
Closed -$237K – 11550
2025
Q4 		$237K Sell
66,500
-23,300
-26% -$143K ﹤0.01% 9358
2025
Q3 		$799K Buy
89,800
+17,200
+24% +$174K ﹤0.01% 6806
2025
Q2 		$669K Sell
72,600
-19,700
-21% -$168K ﹤0.01% 6391
2025
Q1 		$792K Buy
92,300
+52,900
+134% +$500K ﹤0.01% 6005
2024
Q4 		$423K Buy
+39,400
New +$303K ﹤0.01% 7133
2024
Q2 		– Sell
-14,600
Closed -$74.3K – 9335
2024
Q1 		$74.3K Sell
14,600
-56,800
-80% -$320K ﹤0.01% 8643
2023
Q4 		$665K Sell
71,400
-459,100
-87% -$3.16M ﹤0.01% 6281
2023
Q3 		$3.47M Buy
530,500
+426,100
+408% +$3.39M ﹤0.01% 3149
2023
Q2 		$849K Sell
104,400
-181,500
-63% -$1.56M ﹤0.01% 5485
2023
Q1 		$2.45M Buy
285,900
+95,700
+50% +$955K ﹤0.01% 3472
2022
Q4 		$1.76M Buy
190,200
+41,500
+28% +$443K ﹤0.01% 4045
2022
Q3 		$1.53M Sell
148,700
-62,200
-29% -$656K ﹤0.01% 4642
2022
Q2 		$2.11M Sell
210,900
-26,800
-11% -$254K ﹤0.01% 4066
2022
Q1 		$2.93M Buy
237,700
+33,200
+16% +$408K ﹤0.01% 4013
2021
Q4 		$3.55M Sell
204,500
-4,300
-2% -$81.7K ﹤0.01% 3405
2021
Q3 		$3.75M Sell
208,800
-156,800
-43% -$3.12M ﹤0.01% 3237
2021
Q2 		$8.36M Buy
365,600
+316,800
+649% +$4.69M ﹤0.01% 1928
2021
Q1 		$730K Buy
48,800
+7,900
+19% +$86.3K ﹤0.01% 6077
2020
Q4 		$221K Buy
+40,900
New +$216K ﹤0.01% 6818
2017
Q2 		– Sell
-15,000
Closed -$86K – 4307
2017
Q1 		$86K Buy
+15,000
New +$77.5K ﹤0.01% 3984

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Jane Street's AVXL Position: Q1 2026 in Review

Jane Street reduced its Anavex Life Sciences (AVXL) stake by 5.7% in Q1 2026, selling an estimated $190K and leaving 725,003 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #4879.

Jane Street first reported a position in AVXL in Q4 2015 and has held it in 27 quarters since. The position peaked at $4.7M in Q2 2021. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Jane Street held 725,003 shares of Anavex Life Sciences worth $2.23M as of Q1 2026.
  • Jane Street sold 43,952 Anavex Life Sciences shares in Q1 2026, an estimated $190K.
  • Anavex Life Sciences made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4879 holding.
  • Jane Street first reported a position in Anavex Life Sciences in Q4 2015 and has held it in 27 quarters since.
  • Jane Street's Anavex Life Sciences position peaked at $4.7M in Q2 2021.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.